DIA 2019 Global Annual Meeting has ended

Create Your Own Event

DIA 2019 Global Annual Meeting

11:00am PDT

#107: Emerging Technologies in Clinical Research Room 11A #117: International Regulatory Convergence Room 6B #118: Statistical Considerations for Trials Using Surrogate Endpoints for Accelerated Approval Room 3

2:15pm PDT

#142: Show Me the Money! Patient and Caregiver Roles and Compensation in Research, Development, and Innovation Room 5AB #147: Update from Health Canada: The Health Protection Branch Room 6F

3:30pm PDT

#154: Current Initiatives on Patient Involvement in the Medicinal Product Lifecycle: CIOMS XI Room 6C #158: Enhancing Patient-Focused Outcome Assessment in Medical Product Development Room 10 #161: Making Trials Work for Special Populations Room 5AB #169: How Statistics Can Help Improve Data Quality: ICH E6 R2 Room 3

8:00am PDT

#201: To Err is Human: Progress and Challenges in the Prevention of Medication Errors Room 6C #205: Driving Enrollment with a Patient-Centric Focus to Artificial Intelligence Room 10 #208: Patient Focus as Part of the Regulatory Affairs DNA: Opportunities and Challenges Room 5AB #218: Real World Data to Real World Evidence Room 3 #219: Personalized Healthcare and Clinical Outcomes: How Real World Endpoints Can Improve Approval and Access to Medicine? Room 14B

10:30am PDT

#235: Walking the Talk: Using Home Nursing as a Patient-Centric Service in Clinical Trials - From Multiple Perspectives Room 11B

2:00pm PDT

#255: Pharma and Regulatory Perspectives on Machine Learning Applications in Pharmacovigilance Room 6C #256: Wearables and Patient Technologies Utilized in Clinical Trials Room 10 #260: Clinical Trial Disclosure and Transparency: Intersection of Regulators, Industry, and Patients Room 4 #261: Patient Experience Data: How Could this Data Enhance Decision-Making at Different Stages of Medical Product Development? Room 5AB #264: Immuno-Oncology Product Development: Overcoming Scientific and Regulatory Challenges Room 2 #268: Current Status of FDA Framework for the Evaluation of Real World Evidence Room 6B #272: Aligning Facilitated Regulatory and Access Pathways: Observations from the North American Experience Room 14B

4:15pm PDT

#281: Structured Evidence Planning, Production, and Evaluation (SEPPE): A “Quality-Based” Framework for Drug Development Room 6C #289: Impact of Patient Engagement on the Biopharmaceutical Industry's Business and Organization Room 5AB #296: Informing Development and Authorizations Using Real World Evidence/Artificial Intelligence Room 6E #299: Public and Regulatory Response To Drug Pricing Concerns Room 14B

8:00am PDT

#304: Operationalizing Master Protocols Room 10 #308: Identifying High-Value Patient Engagement Opportunities: A Collaborative Three-Step Process for Sponsors and Patient Groups Room 5AB #318: Opportunities and Challenges of Collecting Data in a Pre-Approval Access Setting: A Multi-Stakeholder Perspective Room 14B

10:30am PDT

#334: Understanding and Exploring Elements of a Patient-Focused Product Launch Room 5AB #337: Application of Project Management Methodologies and Tools in NonProfit Institutions Room 15AB #338: Expanding Use of Interactive Response Technologies in Clinical Trials: Maintaining Data Quality and Reliability Room 17AB #339: Hot Topics in Quality and Regulatory Affairs for Combination Products Room 6B

2:00pm PDT

#359: Training for the Electronic Capture of PRO Data in Clinical Trials: Views from ePRO Vendors, Sponsors, Sites, and Patients Room 10 #362: Patient Engagement Quality Guidance: Results and Learnings from Global Multistakeholder Pilots Room 5AB #372: Advancing Value and Access With Technology Room 14B

4:15pm PDT

#379: From Trials to Real World: How Safety Protocols Impact REMS Room 6C #381: A New Path Forward for Using Decentralized Clinical Trials Room 10 #380: Incorporating Patient Input into the Design and Conduct of Clinical Trials Room 9 #384: Patient Preferences in Decision Making and the PREFER Project: Past, Present, and Future Room 5AB #388: Convergence of the Regulatory Pathways for Advanced Therapy Medicinal Products Room 6F

9:00am PDT

#405: eSource and the Sites: Have They Bonded? Room 10 #407: A Patient Engagement Wrap Up: Lessons Learned from DIA 2019 and Where Do We Go from Here Room 5AB #408: FDA Botanicals Room 2